A Study to Determine the Safety and Attack Rate of the Seasonal Flu in Healthy Volunteers
Status:
Completed
Trial end date:
2016-12-28
Target enrollment:
Participant gender:
Summary
This is a non-controlled, open-label, single-centre, dose-escalation study to determine the
safety, infectivity and immunology of the potential novel influenza virus H3N2 challenge
strain. The term 'challenge agent' used in this protocol refers to the Influenza virus H3N2
A/Belgium/4217/2015. The study utilises an adaptive study design and consists of 2 parts.